braskem - BAK

BAK

Close Chg Chg %
3.25 0.07 2.15%

Closed Market

3.32

+0.07 (2.15%)

Volume: 928.70K

Last Updated:

Jan 15, 2026, 4:00 PM EDT

Company Overview: braskem - BAK

BAK Key Data

Open

$3.23

Day Range

3.20 - 3.36

52 Week Range

2.32 - 5.10

Market Cap

$560.72M

Shares Outstanding

172.53M

Public Float

N/A

Beta

1.87

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$2.26

Yield

0.00%

Dividend

$0.63

EX-DIVIDEND DATE

Apr 20, 2022

SHORT INTEREST

N/A

AVERAGE VOLUME

1.03M

 

BAK Performance

1 Week
 
7.47%
 
1 Month
 
18.21%
 
3 Months
 
39.08%
 
1 Year
 
-20.62%
 
5 Years
 
N/A
 

BAK Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 10
Full Ratings ➔

About braskem - BAK

Braskem SA engages in the manufacture of petrochemicals and other related products. It operates through the following segments: Brazil, USA, and Europe and Mexico. The Brazil segment includes production and sale of chemicals, supply of electricity, and production and sale of PE. The USA and Europe segment involves production, operation, and sale of polypropylene in the United States and Germany. The Mexico segment comprises production, operation, and sale of ethylene, high-density polyethylene and low-density polyethylene in Mexico. The company was founded in August 2002 and is headquartered in Butanta, Brazil.

BAK At a Glance

Braskem SA
Rua Eteno, 1561
Camaçari, Bahia 42810-000
Phone 55-11-3576-9531 Revenue 14.36B
Industry Chemicals: Specialty Net Income -2,099,816,108.17
Sector Process Industries 2024 Sales Growth 1.636%
Fiscal Year-end 12 / 2025 Employees 8,382
View SEC Filings

BAK Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.107
Price to Book Ratio N/A
Price to Cash Flow Ratio 3.38
Enterprise Value to EBITDA 15.216
Enterprise Value to Sales 0.755
Total Debt to Enterprise Value 1.101

BAK Efficiency

Revenue/Employee 1,713,128.173
Income Per Employee -250,514.926
Receivables Turnover 13.488
Total Asset Turnover 0.813

BAK Liquidity

Current Ratio 1.31
Quick Ratio 0.826
Cash Ratio 0.593

BAK Profitability

Gross Margin 7.747
Operating Margin -1.434
Pretax Margin -22.88
Net Margin -14.623
Return on Assets -11.888
Return on Equity -8,795.169
Return on Total Capital -18.817
Return on Invested Capital -18.36

BAK Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 106.936
Total Debt to Total Assets 72.579
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 100.938
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Braskem - BAK

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
19.57B 18.69B 14.13B 14.36B
Sales Growth
+72.46% -4.52% -24.40% +1.64%
Cost of Goods Sold (COGS) incl D&A
13.74B 16.49B 13.52B 13.25B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
883.32M 916.48M 1.04B 918.21M
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
+48.80% +19.99% -17.99% -2.04%
Gross Income
5.83B 2.20B 604.82M 1.11B
Gross Income Growth
+175.82% -62.29% -72.50% +83.93%
Gross Profit Margin
+29.79% +11.77% +4.28% +7.75%
2021 2022 2023 2024 5-year trend
SG&A Expense
904.95M 1.02B 971.80M 924.70M
Research & Development
54.96M 72.51M 76.68M 85.88M
Other SG&A
849.99M 950.88M 895.12M 838.81M
SGA Growth
+14.50% +13.09% -5.04% -4.85%
Other Operating Expense
- 70.60M 472.48M 393.62M
Unusual Expense
- 27.80M 35.24M 19.85M
EBIT after Unusual Expense
4.83B 1.18B (874.70M) (225.75M)
Non Operating Income/Expense
(656.65M) (381.69M) 605.02M (1.96B)
Non-Operating Interest Income
81.52M 203.26M 294.10M 232.98M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
844.08M 791.88M 971.39M 1.10B
Interest Expense Growth
+19.02% -6.18% +22.67% +13.30%
Gross Interest Expense
888.09M 862.63M 1.04B 1.23B
Interest Capitalized
44.02M 70.75M 69.07M 132.07M
Pretax Income
3.33B 2.42M (1.24B) (3.29B)
Pretax Income Growth
+277.60% -99.93% -51,392.65% -164.73%
Pretax Margin
+17.00% +0.01% -8.78% -22.88%
Income Tax
741.15M 168.02M (260.67M) (1.05B)
Income Tax - Current - Domestic
710.58M 194.35M 38.24M 61.21M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
30.57M (26.33M) (298.91M) (1.12B)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.59B (158.85M) (979.00M) (2.24B)
Minority Interest Expense
(4.32M) (93.85M) (62.26M) (135.78M)
Net Income
2.59B (65.00M) (916.74M) (2.10B)
Net Income Growth
+299.77% -102.51% -1,310.44% -129.05%
Net Margin Growth
+13.24% -0.35% -6.49% -14.62%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
2.59B (65.00M) (916.74M) (2.10B)
Preferred Dividends
- - - -
-
Net Income Available to Common
2.59B (65.00M) (916.74M) (2.10B)
EPS (Basic)
6.5098 -0.1632 -2.3006 -5.2679
EPS (Basic) Growth
+299.71% -102.51% -1,309.68% -128.98%
Basic Shares Outstanding
398.11M 398.24M 398.47M 398.60M
EPS (Diluted)
6.5017 -0.1632 -2.3006 -5.2679
EPS (Diluted) Growth
+299.46% -102.51% -1,309.68% -128.98%
Diluted Shares Outstanding
398.61M 398.60M 398.47M 398.60M
EBITDA
5.74B 2.09B 202.81M 712.31M
EBITDA Growth
+510.59% -63.54% -90.31% +251.22%
EBITDA Margin
+29.32% +11.20% +1.44% +4.96%

Snapshot

Average Recommendation HOLD Average Target Price 4.196
Number of Ratings 10 Current Quarters Estimate -0.394
FY Report Date 03 / 2026 Current Year's Estimate -1.397
Last Quarter’s Earnings -0.883 Median PE on CY Estimate N/A
Year Ago Earnings -0.608 Next Fiscal Year Estimate -0.353
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 8 6
Mean Estimate -0.39 -0.41 -1.40 -0.35
High Estimates -0.39 -0.41 -0.07 0.74
Low Estimate -0.39 -0.41 -2.82 -1.78
Coefficient of Variance N/A N/A -58.48 -257.88

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 8 8 6
UNDERWEIGHT 0 0 0
SELL 0 0 2
MEAN Hold Hold Hold

Braskem in the News